BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1981409)

  • 1. Retroviral infections transmitted by blood transfusion.
    Sandler SG; Fang C; Williams A
    Yale J Biol Med; 1990; 63(5):353-60. PubMed ID: 1981409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
    Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV;
    Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-transmitted retrovirus infection.
    Williams AE; Sullivan MT
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):115-36. PubMed ID: 7737937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood donor testing for HIV-I/II and HTLV-I/II.
    Ness PM; Nass CC
    Arch Pathol Lab Med; 1994 Apr; 118(4):337-41. PubMed ID: 7909428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
    Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
    East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.
    Davidson F; Lycett C; Jarvis LM; Kerr D; Lumley S; Petrik J; Dow BC
    Vox Sang; 2006 Oct; 91(3):231-6. PubMed ID: 16958835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
    Stramer SL; Foster GA; Dodd RY
    Transfusion; 2006 May; 46(5):703-7. PubMed ID: 16686837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of HIV type 1 western blot-indeterminate blood donors for the presence of human or bovine retroviruses.
    Sherman MP; Dock NL; Ehrlich GD; Sninsky JJ; Brothers C; Gillsdorf J; Bryz-Gornia V; Poiesz BJ
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):409-14. PubMed ID: 7786586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of triple retroviral infection with HIV-1 (genotype C3), HIV-2 and HTLV-I.
    Ramalingam S; Kannangai R; Prakash KJ; Jesudason MV; Sridharan G
    Natl Med J India; 2000; 13(5):274-5. PubMed ID: 11190060
    [No Abstract]   [Full Text] [Related]  

  • 14. [The actual risk of retrovirus transmission from transfusions].
    Soriano V; Mas A
    Sangre (Barc); 1995 Oct; 40(5):407-16. PubMed ID: 8553176
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of human T-lymphotropic virus type-I and type-II testing in donors and patients.
    Fischer HE; Lichtiger B; Glassman AB
    Ann Clin Lab Sci; 1995; 25(5):373-80. PubMed ID: 7486811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group.
    Sullivan MT; Williams AE; Fang CT; Grandinetti T; Poiesz BJ; Ehrlich GD
    Arch Intern Med; 1991 Oct; 151(10):2043-8. PubMed ID: 1929693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria.
    de Almeida Neto C; McFarland W; Murphy EL; Chen S; Nogueira FA; Mendrone A; Salles NA; Chamone DA; Sabino EC
    Transfusion; 2007 Apr; 47(4):608-14. PubMed ID: 17381618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
    Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-I in HIV seropositive Indian blood donors.
    Malhotra VL; Lakshmy A
    J Commun Dis; 1996 Dec; 28(4):270-2. PubMed ID: 9057451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of HTLV-1 and HIV-2 for transfusion medicine in Europe].
    Gürtler L
    Beitr Infusionsther; 1989; 24():27-32. PubMed ID: 2481545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.